Mir Imran
the future of biologic drug delivery , and we believe our culture has helped us tremendously in that regard . I ’ m proud that today Rani ’ s workforce is more than 50 % women , and that 20 % are over 50 years old . Our employees are ethnically diverse as well , drawn from more than 10 countries . For me , building a wellrounded , holistically representative workforce means finding the best talent regardless of a person ’ s age , gender , or ethnicity .
A criticism that ’ s often levelled at pharmaceutical and tech companies is that they ’ re increasingly driven by the business case as opposed to the desire to innovate and improve people ’ s lives . How do you ensure that Rani Therapeutics doesn ’ t lose sight of the goal of helping humanity ?
EXECUTIVE PROFILE
Mir Imran
Mir Imran is the Chairman and CEO of Rani Therapeutics , an exciting company that has developed a unique approach for the oral delivery of large drug molecules including peptides , proteins , and antibodies . Imran is also the Chairman & CEO of InCube Labs , a life sciences R & D lab focused on developing and commercialising breakthrough medical innovations . Rani spun out of InCube in 2012 . After attending medical school , Imran began his life as a healthcare entrepreneur in the late 1970s and has founded more than 20 life sciences companies since those early days , more than half of which have been acquired . Imran ’ s passion is creating novel technologies that have the potential to positively impact the lives of millions of patients and has become one of the leading inventors and entrepreneurs in the field . Imran holds more than 500 issued and pending patents and is perhaps most wellknown for his pioneering contributions to the first FDA-approved Automatic Implantable Cardioverter Defibrillator ( ICD ).
55 www . businesschief . com